
|Articles|November 26, 2007
Alcon makes final push for WaveLight
Alcon has received all the required regulatory clearances relating to its tender offer for WaveLight AG.
Advertisement
Alcon has received all the required regulatory clearances relating to its tender offer for WaveLight AG.
Upon settlement of all tendered shares, Alcon will own 77.4% of the outstanding WaveLight shares and shareholders who tendered their shares under the offer will automatically receive payment.
Newsletter
Don’t miss out—get Ophthalmology Times updates on the latest clinical advancements and expert interviews, straight to your inbox.
SubscribeAdvertisement
Latest CME
Advertisement
Advertisement
Trending on Eye Care Network - Ophthalmology Times
1
FDA grants RMAT designation to Emmecell's EO2002 for corneal endothelial disease
2
NeuroOp Guru: What a big data study reveals about NAION and stroke risk
3
Port Delivery System Therapies in Retinal Vascular Diseases
4
Polyendocrine metabolic ovarian syndrome: looking past the reproductive system to the eye
5






















